Mediolanum International Funds LTD Biomarin Pharmaceutical Inc Transaction History
Mediolanum International Funds LTD
- $7.71 Trillion
- Q4 2024
A detailed history of Mediolanum International Funds LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mediolanum International Funds LTD holds 18,939 shares of BMRN stock, worth $1.18 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,939Holding current value
$1.18 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
641Shares Held
177MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.41 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.2 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.17 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$864 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$653 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...